Iradimed Corporation (IRMD) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Iradimed Corporation  (NASDAQ: IRMD)


Iradimed's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Iradimed's ROI in the second quarter of 2026?
Iradimed Corporation achieved a return on average invested assets (ROI) of 22.57 % in its second quarter of 2026, this is above IRMD's average return on investment of 14.67%.
Iradimed Corporation invested over the 12 months ending in its second quarter of 2026 $102 million

ROI decreased relative to the period ending Mar 31 2026, due to the decline in net income.

Within the Healthcare sector 44 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 241, from total ROI ranking in the first quarter of 2026 at 247.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 11.37 % 13.84 % 15.5 % 19.2 % 16.72 %
Y / Y Net Income Change TTM 11.6 % 19.34 % 48.9 % 112.9 % 321.48 %
Investment (TTM) in Millions 106 102 99 102 98
Return On Investment (TTM) 22.57 % 23.59 % 22.97 % 22.15 % 22.52 %
IRMD's Overall Ranking # 241 # 247 # 163 # 191 # 202
Seq. Investment Change TTM 2.04 % 2.3 % 2.3 % 4.29 % 4.3 %
Seq. Net Income Change TTM -2.35 % 5.03 % 6.11 % 2.55 % 4.41 %
Net Income (TTM) in Millions 23 24 22 21 21

IRMD Company Profile >> Back to IRMD Roi Comparisons >> See Annual IRMD Return On Investment



Return On Investment IRMD's Ranking
Within: No.
Industry # 8
Sector # 45
Overall # 241

Return On Investment Statistics
High Average Low
29.28 %
14.67 %
-22.2 %
(Jun 30 2016)   (Mar 31 2015)







Financial Statements
Iradimed's II. Quarter Investments $ 106 Millions IRMD's Balance sheet
Iradimed's II. Quarter Income $ 5 Millions Quarterly IRMD's Income Statement
IRMD's Income by Division See IRMD's Income by Division


IRMD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 99 90 72 77 76
Y / Y Investment Growth 9.78 % 24.89 % -6.55 % 1.19 % 14.98 %
Net Income in Millions 22 19 17 13 9
Y / Y Net Income Growth 16.88 % 11.87 % 34.02 % 37.56 % 581.19 %
Annual Return On Investment 22.8 % 21.42 % 23.91 % 16.67 % 12.26 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 22.8 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IRMD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IRMD's Competitors
Subscribers only: Roi for Iradimed's Suppliers
Subscribers only: Return On Investment for IRMD's Customers

Other Ratios
IRMD's Roa IRMD's Inventory Turnover Ratio IRMD's Growth Rates IRMD's Dividend Statistics
IRMD's Profitability Ratios IRMD's Asset Turnover Ratio IRMD's Dividend Growth
IRMD's Roe IRMD's Valuation Ratios IRMD's Financial Strength Ratios IRMD's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Meiragtx Holdings Plc  55.83 %
Elite Pharmaceuticals Inc   53.48 %
Idexx Laboratories Inc  51.80 %
Aurinia Pharmaceuticals Inc   50.35 %
Qhslab Inc   48.94 %
Q32 Bio Inc   47.43 %
Vaxart Inc   46.17 %
Liquidia Corporation  42.09 %
Tg Therapeutics Inc   39.26 %
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %

Date modified: 2026-08-30T23:19:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.